speb/financial-data huggingface dataset:
NICU.V cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 83099.00
NICU.V cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 11782.00
NICU.V income_statement (annual, 2024-12-31) — Diluted Average Shares: 170766096.00
NICU.V income_statement (annual, 2024-12-31) — Diluted EPS: -0.10
NICU.V income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -16268000.00
NICU.V income_statement (annual, 2024-12-31) — EBIT: -16095000.00
NICU.V income_statement (annual, 2024-12-31) — EBITDA: -16012000.00
NICU.V cash_flow (annual, 2024-12-31) — End Cash Position: 17535000.00
NICU.V balance_sheet (annual, 2024-12-31) — Financial Assets: 0.00
NICU.V cash_flow (annual, 2024-12-31) — Financing Cash Flow: 24641000.00
NICU.V cash_flow (annual, 2024-12-31) — Free Cash Flow: -17834000.00
NICU.V cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
NICU.V income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 5000.00
NICU.V income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -12000.00
NICU.V income_statement (annual, 2024-12-31) — General And Administrative Expense: 9098000.00
NICU.V balance_sheet (annual, 2024-12-31) — Gross PPE: 17652000.00
NICU.V income_statement (annual, 2024-12-31) — Gross Profit: 0.00
NICU.V income_statement (annual, 2024-12-31) — Interest Expense: 173000.00
NICU.V income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 173000.00
NICU.V income_statement (annual, 2024-12-31) — Interest Income: 401247.00
NICU.V income_statement (quarterly, 2024-12-31) — Interest Income: 96735.00
NICU.V income_statement (annual, 2024-12-31) — Interest Income Non Operating: 401247.00
NICU.V income_statement (quarterly, 2024-12-31) — Interest Income Non Operating: 96735.00
NICU.V cash_flow (annual, 2024-12-31) — Interest Paid Cff: 0.00
NICU.V balance_sheet (annual, 2024-12-31) — Inventory: 0.00
NICU.V balance_sheet (annual, 2024-12-31) — Invested Capital: 35043000.00
NICU.V cash_flow (annual, 2024-12-31) — Investing Cash Flow: -186000.00
NICU.V cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 20333000.00
NICU.V cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
NICU.V balance_sheet (annual, 2024-12-31) — Line Of Credit: 0.00
NICU.V balance_sheet (quarterly, 2024-12-31) — Line Of Credit: 0.00
NICU.V balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 10000.00
NICU.V balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 10000.00
NICU.V cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
NICU.V cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -45000.00
NICU.V cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: -11158.00
NICU.V balance_sheet (annual, 2024-12-31) — Long Term Provisions: 875000.00
NICU.V balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 113211.00
NICU.V balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 113211.00
NICU.V cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 20333000.00
NICU.V income_statement (annual, 2024-12-31) — Net Income: -16268000.00
NICU.V income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -16268000.00
NICU.V income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -16268000.00
NICU.V income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -16268000.00
NICU.V income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -16268000.00
NICU.V cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -16268000.00
NICU.V income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -16268000.00
NICU.V income_statement (annual, 2024-12-31) — Net Interest Income: -173000.00
NICU.V cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 0.00
NICU.V cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -45000.00
NICU.V cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -45000.00
NICU.V income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -173000.00
NICU.V cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -198000.00
NICU.V cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -168000.00
NICU.V balance_sheet (annual, 2024-12-31) — Net PPE: 17652000.00
NICU.V cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -18000.00
NICU.V balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 35043000.00
NICU.V balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 0.00
NICU.V balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 0.00
NICU.V balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 0.00
NICU.V income_statement (annual, 2024-12-31) — Normalized EBITDA: -16005000.00
NICU.V income_statement (annual, 2024-12-31) — Normalized Income: -16261000.00
NICU.V cash_flow (annual, 2024-12-31) — Operating Cash Flow: -17810000.00
NICU.V cash_flow (annual, 2024-12-31) — Operating Gains Losses: -5496.00
NICU.V income_statement (annual, 2024-12-31) — Operating Income: -19484000.00
NICU.V income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
NICU.V balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 194910244.00
NICU.V balance_sheet (annual, 2024-12-31) — Other Equity Interest: 5374661.00
NICU.V income_statement (annual, 2024-12-31) — Other Gand A: 7258000.00
NICU.V income_statement (annual, 2024-12-31) — Other Income Expense: 3389000.00
NICU.V cash_flow (annual, 2024-12-31) — Other Non Cash Items: -3204000.00
NICU.V balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 944000.00
NICU.V income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 3396000.00
NICU.V income_statement (annual, 2024-12-31) — Other Operating Expenses: 10140000.00
NICU.V balance_sheet (annual, 2024-12-31) — Other Properties: 17739731.00
NICU.V balance_sheet (quarterly, 2024-12-31) — Other Properties: 17739731.00
NICU.V balance_sheet (annual, 2024-12-31) — Other Receivables: 500000.00
NICU.V balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 41021.00
NICU.V balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 41021.00
NICU.V balance_sheet (annual, 2024-12-31) — Payables: 1258000.00
NICU.V balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 3607000.00
NICU.V balance_sheet (annual, 2024-12-31) — Prepaid Assets: 213000.00
NICU.V income_statement (annual, 2024-12-31) — Pretax Income: -16268000.00
NICU.V cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 4551000.00
NICU.V cash_flow (annual, 2024-12-31) — Purchase Of Investment: 0.00
NICU.V cash_flow (annual, 2024-12-31) — Purchase Of PPE: -24000.00
NICU.V balance_sheet (annual, 2024-12-31) — Raw Materials: 0.00
NICU.V balance_sheet (quarterly, 2024-12-31) — Raw Materials: 0.00
NICU.V balance_sheet (annual, 2024-12-31) — Receivables: 3029000.00
NICU.V income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 0.00
NICU.V income_statement (annual, 2024-12-31) — Reconciled Depreciation: 83000.00
NICU.V cash_flow (annual, 2024-12-31) — Repayment Of Debt: -45000.00
NICU.V cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: -11158.00
NICU.V income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
NICU.V balance_sheet (annual, 2024-12-31) — Retained Earnings: -41616000.00
NICU.V income_statement (annual, 2024-12-31) — Salaries And Wages: 1840000.00
NICU.V cash_flow (annual, 2024-12-31) — Sale Of PPE: 6000.00
NICU.V income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 261151.00
NICU.V income_statement (quarterly, 2024-12-31) — Selling And Marketing Expense: 81331.00
NICU.V income_statement (annual, 2024-12-31) — Selling General And Administration: 9098000.00
NICU.V balance_sheet (annual, 2024-12-31) — Share Issued: 194910244.00
NICU.V income_statement (annual, 2024-12-31) — Special Income Charges: 5000.00
NICU.V cash_flow (annual, 2024-12-31) — Stock Based Compensation: 1579000.00
NICU.V balance_sheet (annual, 2024-12-31) — Stockholders Equity: 35043000.00
NICU.V balance_sheet (annual, 2024-12-31) — Tangible Book Value: 35043000.00
NICU.V income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
NICU.V income_statement (annual, 2024-12-31) — Tax Provision: 0.00
NICU.V income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
NICU.V balance_sheet (annual, 2024-12-31) — Taxes Receivable: 1155000.00
NICU.V balance_sheet (annual, 2024-12-31) — Total Assets: 39571000.00
NICU.V balance_sheet (annual, 2024-12-31) — Total Capitalization: 35043000.00
NICU.V balance_sheet (annual, 2024-12-31) — Total Debt: 46000.00
NICU.V balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 35043000.00
NICU.V income_statement (annual, 2024-12-31) — Total Expenses: 19484000.00
NICU.V balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 4528000.00
NICU.V balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 18596000.00
NICU.V balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 885000.00
NICU.V income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -19461000.00
NICU.V income_statement (annual, 2024-12-31) — Total Unusual Items: -7000.00
NICU.V income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -7000.00
NICU.V balance_sheet (annual, 2024-12-31) — Working Capital: 17332000.00
NICU.V income_statement (quarterly, 2025-03-31) — +Operating Expense: 5226000.00
NICU.V income_statement (quarterly, 2025-03-31) — +Total Revenue: 4296000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 5851000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 5100000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -439000.00
NICU.V income_statement (quarterly, 2025-03-31) — Basic Average Shares: 197739067.00
NICU.V income_statement (quarterly, 2025-03-31) — Basic EPS: 0.06
NICU.V cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 17535000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 36000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Capital Stock: 83466000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 38250000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 38308000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: 0.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Cash Financial: 38250000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 31344000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -8000000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -2629000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 7511000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Change In Income Tax Payable: 0.00
NICU.V cash_flow (quarterly, 2025-03-31) — Change In Inventory: -350000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Change In Payable: 7511000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 7511000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -269000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Change In Receivables: -3168000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Change In Tax Payable: 0.00
NICU.V cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 3724000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -3168000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Changes In Cash: 20715000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Common Stock: 83466000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 84617000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 9394000.00
NICU.V income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 4581000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 5311000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Current Assets: 54244000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 32000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 32000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Current Deferred Assets: 933000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 3720000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 3720000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 14914000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 0.00
NICU.V cash_flow (quarterly, 2025-03-31) — Deferred Tax: 0.00
NICU.V cash_flow (quarterly, 2025-03-31) — Depreciation: 238000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 1041000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 238000.00
NICU.V income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 224792704.00
NICU.V income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.05
NICU.V income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 11039000.00
NICU.V income_statement (quarterly, 2025-03-31) — EBIT: 11548000.00
NICU.V income_statement (quarterly, 2025-03-31) — EBITDA: 12589000.00
NICU.V cash_flow (quarterly, 2025-03-31) — End Cash Position: 38250000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Financial Assets: 107000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 31344000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -2629000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 2000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of Business: -36575000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: 0.00
NICU.V income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -29000.00
NICU.V income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 3031000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Gross PPE: 110308000.00
NICU.V income_statement (quarterly, 2025-03-31) — Gross Profit: -285000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 0.00
NICU.V income_statement (quarterly, 2025-03-31) — Interest Expense: 509000.00
NICU.V income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 509000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Interest Paid Cff: -173000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 0.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Inventory: 8324000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Invested Capital: 99131000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -8000000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 9394000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 22335000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 4000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 14514000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 14518000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 22335000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -12000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 9912000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 9394000.00
NICU.V income_statement (quarterly, 2025-03-31) — Net Income: 11039000.00
NICU.V income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 11039000.00
NICU.V income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 11039000.00
NICU.V income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 11039000.00
NICU.V income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 11039000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 11039000.00
NICU.V income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 11039000.00
NICU.V income_statement (quarterly, 2025-03-31) — Net Interest Income: -586000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 22323000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 22323000.00
NICU.V income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -586000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -812000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -8000000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Net PPE: 109869000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 0.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 84617000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 37440000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 14883000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 20652000.00
NICU.V income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -4438000.00
NICU.V income_statement (quarterly, 2025-03-31) — Normalized Income: -5988000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -2629000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 2000.00
NICU.V income_statement (quarterly, 2025-03-31) — Operating Income: -5511000.00
NICU.V income_statement (quarterly, 2025-03-31) — Operating Revenue: 4296000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 203529422.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 13669000.00
NICU.V income_statement (quarterly, 2025-03-31) — Other Gand A: 2537000.00
NICU.V income_statement (quarterly, 2025-03-31) — Other Income Expense: 17136000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -18929000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 3912000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 6731000.00
NICU.V income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 109000.00
NICU.V income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 1257000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Other Properties: 53864000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Other Receivables: 300000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 58000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Payables: 5851000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 11162000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 482000.00
NICU.V income_statement (quarterly, 2025-03-31) — Pretax Income: 11039000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 612000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: 0.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Raw Materials: 8324000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Receivables: 6197000.00
NICU.V income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 4581000.00
NICU.V income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 1041000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -12000.00
NICU.V income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: -17056000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -12518000.00
NICU.V income_statement (quarterly, 2025-03-31) — Salaries And Wages: 494000.00
NICU.V income_statement (quarterly, 2025-03-31) — Selling General And Administration: 3031000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Share Issued: 203529422.00
NICU.V income_statement (quarterly, 2025-03-31) — Special Income Charges: 17056000.00
NICU.V cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 494000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 84617000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 84617000.00
NICU.V income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
NICU.V income_statement (quarterly, 2025-03-31) — Tax Provision: 0.00
NICU.V income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 797000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Total Assets: 168132000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 99131000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Total Debt: 14550000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 84617000.00
NICU.V income_statement (quarterly, 2025-03-31) — Total Expenses: 9807000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 83515000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 113888000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 68601000.00
NICU.V income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -5469000.00
NICU.V income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: 77000.00
NICU.V income_statement (quarterly, 2025-03-31) — Total Unusual Items: 17027000.00
NICU.V income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 17027000.00
NICU.V balance_sheet (quarterly, 2025-03-31) — Working Capital: 39330000.00
NICU.V income_statement (quarterly, 2025-06-30) — +Operating Expense: 8447000.00
NICU.V income_statement (quarterly, 2025-06-30) — +Total Revenue: 18465000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 10948000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 16579000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -4319000.00
NICU.V income_statement (quarterly, 2025-06-30) — Basic Average Shares: 203646528.00
NICU.V income_statement (quarterly, 2025-06-30) — Basic EPS: -0.05
NICU.V cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 38250000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -2080000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 25000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Capital Stock: 83784000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 27018000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 27018000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: 0.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Cash Financial: 27018000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -519000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 846000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -11560000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 4320000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Change In Inventory: 185000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Change In Payable: 7323000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 7323000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 63000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Change In Receivables: -11777000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -4206000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Changes In Cash: -11232000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Common Stock: 83784000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 75943000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
NICU.V income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 20275000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 4600000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Current Assets: 54229000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 25000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 25000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Current Deferred Assets: 780000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 3739000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 3739000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 22315000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -2268000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Deferred Tax: -2268000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 3881000.00
NICU.V income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 203646528.00
NICU.V income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.05
NICU.V income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -9501000.00
NICU.V income_statement (quarterly, 2025-06-30) — EBIT: -10700000.00
NICU.V income_statement (quarterly, 2025-06-30) — EBITDA: -6819000.00
NICU.V cash_flow (quarterly, 2025-06-30) — End Cash Position: 27018000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Financial Assets: 214000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -519000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -13640000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -107000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of Business: 0.00
NICU.V income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -305000.00
NICU.V income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 2791000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Gross PPE: 112388000.00
NICU.V income_statement (quarterly, 2025-06-30) — Gross Profit: -1810000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 0.00
NICU.V income_statement (quarterly, 2025-06-30) — Interest Expense: 1069000.00
NICU.V income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 1069000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Interest Paid Cff: -615000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 615000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Inventory: 8139000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Invested Capital: 90811000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 846000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
NICU.V cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 0.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 0.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 14868000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 14868000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 0.00
NICU.V cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -11000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 10009000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 55335000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
NICU.V cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: 101000.00
NICU.V income_statement (quarterly, 2025-06-30) — Net Income: -9501000.00
NICU.V income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -9501000.00
NICU.V income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -9501000.00
NICU.V income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -9501000.00
NICU.V income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -9501000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -9501000.00
NICU.V income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -9501000.00
NICU.V income_statement (quarterly, 2025-06-30) — Net Interest Income: -1341000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -11000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -11000.00
NICU.V income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -1341000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -119000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 2926000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Net PPE: 108069000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -2080000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 75943000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 33617000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 13315000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 18384000.00
NICU.V income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -6428000.00
NICU.V income_statement (quarterly, 2025-06-30) — Normalized Income: -9185349.48
NICU.V cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -11560000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -6000.00
NICU.V income_statement (quarterly, 2025-06-30) — Operating Income: -10257000.00
NICU.V income_statement (quarterly, 2025-06-30) — Operating Revenue: 18465000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 203965054.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: 14178000.00
NICU.V income_statement (quarterly, 2025-06-30) — Other Gand A: 2191000.00
NICU.V income_statement (quarterly, 2025-06-30) — Other Income Expense: -171000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -60000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 1022000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 6782000.00
NICU.V income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 220000.00
NICU.V income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 1919000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Other Payable: 3003000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Other Properties: 141000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Other Receivables: 231000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Payables: 13951000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 18551000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 419000.00
NICU.V income_statement (quarterly, 2025-06-30) — Pretax Income: -11769000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 226000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -2080000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Raw Materials: 8139000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Receivables: 17873000.00
NICU.V income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 20275000.00
NICU.V income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 3881000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -11000.00
NICU.V income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 86000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -22019000.00
NICU.V income_statement (quarterly, 2025-06-30) — Salaries And Wages: 600000.00
NICU.V income_statement (quarterly, 2025-06-30) — Selling General And Administration: 2791000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Share Issued: 203965054.00
NICU.V income_statement (quarterly, 2025-06-30) — Special Income Charges: -86000.00
NICU.V cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 600000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 75943000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 75943000.00
NICU.V income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -75349.48
NICU.V income_statement (quarterly, 2025-06-30) — Tax Provision: -2268000.00
NICU.V income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.19
NICU.V balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 1063000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Total Assets: 163534000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 90811000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Total Debt: 14893000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 75943000.00
NICU.V income_statement (quarterly, 2025-06-30) — Total Expenses: 28722000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 87591000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 109305000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 65276000.00
NICU.V income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -10160000.00
NICU.V income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: 272000.00
NICU.V income_statement (quarterly, 2025-06-30) — Total Unusual Items: -391000.00
NICU.V income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -391000.00
NICU.V balance_sheet (quarterly, 2025-06-30) — Working Capital: 31914000.00
NICU.V income_statement (quarterly, 2025-09-30) — +Operating Expense: 8739000.00
NICU.V income_statement (quarterly, 2025-09-30) — +Total Revenue: 16282000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 5831000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 25748000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -7550000.00
NICU.V income_statement (quarterly, 2025-09-30) — Basic Average Shares: 211307866.00
NICU.V income_statement (quarterly, 2025-09-30) — Basic EPS: -22.00
NICU.V cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 27018000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -4235000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 39000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Capital Stock: 135294000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 63121000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 63121000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: 0.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Cash Financial: 63121000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 50453000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -3569000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -10781000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 6798000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Change In Inventory: 107000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Change In Payable: 9176000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 9176000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -370000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Change In Receivables: -11453000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -2540000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Changes In Cash: 36103000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Common Stock: 135294000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 117984000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 47435000.00
NICU.V income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 19380000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 16590000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Current Assets: 101963000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 39000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 39000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Current Deferred Assets: 594000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 3729000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 3729000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 31570000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -2339000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Deferred Tax: -2339000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 3231000.00
NICU.V income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 211307866.00
NICU.V income_statement (quarterly, 2025-09-30) — Diluted EPS: -22.00
NICU.V income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -10642000.00
NICU.V income_statement (quarterly, 2025-09-30) — EBIT: -11740000.00
NICU.V income_statement (quarterly, 2025-09-30) — EBITDA: -8509000.00
NICU.V cash_flow (quarterly, 2025-09-30) — End Cash Position: 63121000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Financial Assets: 521000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 50453000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -15016000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -307000.00
NICU.V income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 471000.00
NICU.V income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 2758000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Gross PPE: 116699000.00
NICU.V income_statement (quarterly, 2025-09-30) — Gross Profit: -3098000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 8000.00
NICU.V income_statement (quarterly, 2025-09-30) — Interest Expense: 1233000.00
NICU.V income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 1233000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Interest Paid Cff: -900000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 897000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Inventory: 8032000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Invested Capital: 133248000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -3569000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 47435000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 0.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 15264000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 15264000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 0.00
NICU.V cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -11000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 10633000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 56789000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 47435000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: -102000.00
NICU.V income_statement (quarterly, 2025-09-30) — Net Income: -10642000.00
NICU.V income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -10642000.00
NICU.V income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -10642000.00
NICU.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -10642000.00
NICU.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -10642000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -10642000.00
NICU.V income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -10642000.00
NICU.V income_statement (quarterly, 2025-09-30) — Net Interest Income: -1557000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -11000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -11000.00
NICU.V income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -1557000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -137000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 666000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Net PPE: 109149000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -4235000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 117984000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 30361000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 12384000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 16045000.00
NICU.V income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -8888000.00
NICU.V income_statement (quarterly, 2025-09-30) — Normalized Income: -10952900.95
NICU.V cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -10781000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -409000.00
NICU.V income_statement (quarterly, 2025-09-30) — Operating Income: -11837000.00
NICU.V income_statement (quarterly, 2025-09-30) — Operating Revenue: 16282000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 234810643.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 15351000.00
NICU.V income_statement (quarterly, 2025-09-30) — Other Gand A: 1576000.00
NICU.V income_statement (quarterly, 2025-09-30) — Other Income Expense: 421000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 736000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 1023000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 6844000.00
NICU.V income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 42000.00
NICU.V income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 2739000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Other Payable: 5381000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Other Properties: 166000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Other Receivables: 2694000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Payables: 11212000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 27802000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 789000.00
NICU.V income_statement (quarterly, 2025-09-30) — Pretax Income: -12973000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 4066000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -4235000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Raw Materials: 8032000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Receivables: 29427000.00
NICU.V income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 19380000.00
NICU.V income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 3231000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -11000.00
NICU.V income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 92000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -32661000.00
NICU.V income_statement (quarterly, 2025-09-30) — Salaries And Wages: 1182000.00
NICU.V income_statement (quarterly, 2025-09-30) — Selling General And Administration: 2758000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Share Issued: 234810643.00
NICU.V income_statement (quarterly, 2025-09-30) — Special Income Charges: -92000.00
NICU.V cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 1182000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 117984000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 117984000.00
NICU.V income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 68099.05
NICU.V income_statement (quarterly, 2025-09-30) — Tax Provision: -2331000.00
NICU.V income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.18
NICU.V balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 985000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Total Assets: 212656000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 133248000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Total Debt: 15303000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 117984000.00
NICU.V income_statement (quarterly, 2025-09-30) — Total Expenses: 28119000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 94672000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 110693000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 63102000.00
NICU.V income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -11779000.00
NICU.V income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: 324000.00
NICU.V income_statement (quarterly, 2025-09-30) — Total Unusual Items: 379000.00
NICU.V income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 379000.00
NICU.V balance_sheet (quarterly, 2025-09-30) — Working Capital: 70393000.00
NICU.V income_statement (annual, 2025-12-31) — +Operating Expense: 31134000.00
NICU.V income_statement (quarterly, 2025-12-31) — +Operating Expense: 9137000.00
NICU.V income_statement (annual, 2025-12-31) — +Total Revenue: 64970000.00
NICU.V income_statement (quarterly, 2025-12-31) — +Total Revenue: 25769000.00
NICU.V balance_sheet (annual, 2025-12-31) — Accounts Payable: 1345000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 1345000.00
NICU.V balance_sheet (annual, 2025-12-31) — Accounts Receivable: 21678000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 21678000.00
NICU.V balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -11737000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -11737000.00
NICU.V balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 7863000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 7863000.00
NICU.V income_statement (annual, 2025-12-31) — Basic Average Shares: 215042407.00
NICU.V income_statement (annual, 2025-12-31) — Basic EPS: -0.08
NICU.V cash_flow (annual, 2025-12-31) — Beginning Cash Position: 17535000.00
NICU.V cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 63121000.00
NICU.V cash_flow (annual, 2025-12-31) — Capital Expenditure: -7798000.00
NICU.V cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -1483000.00
NICU.V balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 216000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 216000.00
NICU.V balance_sheet (annual, 2025-12-31) — Capital Stock: 141433000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Capital Stock: 141433000.00
NICU.V balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 55899000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 55899000.00
NICU.V balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 55899000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 55899000.00
NICU.V cash_flow (annual, 2025-12-31) — Cash Dividends Paid: 0.00